Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: The Atherosclerosis Risk in Communities Study

Diabetes

Volumn 51, Issue 10, 2002, Pages 3069-3076

  Golden, Sherita Hill ^a   Folsom, Aaron R ^b   Coresh, Josef ^a   Richey Sharrett, A ^c   Szklo, Moyses ^a   Brancati, Frederick ^a,d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; B SCAN; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN TISSUE; HYPERINSULINISM; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; MULTIVARIATE ANALYSIS; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0036788311     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.10.3069     Document Type: Article

References (42)

1. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263:2893-2898, 1990
2. Stern MP: Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents? Ann Intern Med 124:110-116, 1996
3. Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP: Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation 101:975-980, 2000
4. Liese AD, Mayer-Davis EJ, Chambless LE, Folsom AR, Sharrett AR, Brancati FL, Heiss G: Elevated fasting insulin predicts incident hypertension: the ARIC study. Atherosclerosis Risk in Communities Study Investigators. J Hypertens 17:1169-1177, 1999
5. Meigs JB, D'Agostino RB Sr, Wilson PW, Cupples LA, Nathan DM, Singer DE: Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 46:1594-1600, 1997
6. Nabulsi AA, Folsom AR, Heiss G, Weir SS, Chambless LE, Watson RL, Eckfeldt JH: Fasting hyperinsulinemia and cardiovascular disease risk factors in nondiabetic adults: stronger associations in lean versus obese subjects. Atherosclerosis Risk in Communities Study Investigators. Metabolism 44:914-922, 1995
7. Haffner SM, D'Agostino R Jr, Mykkanen L, Tracy R, Howard B, Rewers M, Selby J, Savage PJ, Saad MF: Insulin sensitivity in subjects with type 2 diabetes: relationship to cardiovascular risk factors. The Insulin Resistance Atherosclerosis Study. Diabetes Care 22:562-568, 1999
8. Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K: Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 20:538-544, 2000
9. Lempiainen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J: Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 100:123-128, 1999
10. Lehto S, Ronnemaa T, Pyorala K, Laakso M: Cardiovascular risk factors clustering with endogenous hyperinsulinemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia 43:148-155, 2000
11. Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, Schmidt MI, Heiss G: Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care 22:1077-1083, 1999
12. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847, 1998
13. Garg A, Helderman JH, Koffier M, Ayuso R, Rosenstock J, Raskin P: Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 37:982-987, 1988
14. Laakso M, Sarlund H, Mykkanen L: Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 10:223-231, 1990
15. Abbott WG, Lillioja S, Young AA, Zawadzki JK, Yki-Jarvinen H, Christin L, Howard BV: Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes 36:897-904, 1987
16. Sheu WH, Jeng CY, Young MS, Le WJ, Chen YT: Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes. Am J Med Sci 319:84-88, 2000
17. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
18. The ARIC Investigators: The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 129:687-702, 1989
19. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
20. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R: Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74:1399-1406, 1986
21. National Heart Lung and Blood Institute: ARIC Manuals of Operation. Chapel Hill, NC, ARIC Coordinating Center, School of Public Health, University of North Carolina, 1987
22. Chambless LE, Zhong MM, Amett D, Folsom AR, Riley WA, Heiss G: Variability in B-mode ultrasound measurements in the Atherosclerosis Risk in Communities (ARIC) Study. Ultrasound Med Biol 22:545-554, 1996
23. Multiple comparisons. In Biostatistics: A Methodology for the Health Sciences. Fisher LD, Van Belle G, Eds. New York, Wiley & Sons, 1993, p. 596-629
24. Stata Reference Manuals, Release 6:0. College Station, Texas, Stata Press, 1999
25. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 269:3015-3023, 1993
26. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG: Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke 25:66-73, 1994
27. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 146:483-494, 1997
28. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP: The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 128:262-269, 1998
29. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41:715-722, 1992
30. Haffner SM: Progress in population analyses of the insulin resistance syndrome. Ann N Y Acad Sci 827:1-12, 1997
31. Juhan-Vague I: AMMP: PAI-1, obesity, and insulin resistance. In Insulin Resistance: The IRS X. Reaven GM, Laws A, Eds. Totowa, NJ, Humana Press, 1999, p. 317-332
32. Temelkova-Kurktschiev T, Koehler C, Schaper F, Henkel E, Hahnefeld A, Fuecker K, Siegert G, Hanefeld M: Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals. Diabetologia 41:706-712, 1998
33. Temelkova-Kurktschiev TS, Koehler C, Leonhardt W, Schaper F, Henkel E, Siegert G, Hanefeld M: Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors. Diabetes Care 22:333-338, 1999
34. Howard BV, Mayer-Davis EJ, Goff D, Zaccaro DJ, Laws A, Robbins DC, Saad MF, Selby J, Hamman RF, Krauss RM, Haffner SM: Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Metabolism 47:1174-1179, 1998
35. Laakso M, Barrett-Connor E: Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis. Arteriosclerosis 9:665-672, 1989
36. Burchfiel CM, Abbott RD, Curb JD, Sharp DS, Rodriguez BL, Arakaki R, Yano K: Association of insulin levels with hpids and lipoproteins in elderly Japanese-American men. Ann Epidemiol 8:92-98, 1998
37. Laws A: Insulin resistance and dyslipidemia. In Insulin Resistance. The IRS X. Reaven GM, Laws A, Eds. Totowa, NJ, Humana Press, 1999, p. 267-280
38. Edwards KL, Burchfiel CM, Sharp DS, Curb JD, Rodriguez BL, Fujimoto WY, LaCroix AZ, Vitiello MV, Austin MA: Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men. Am J Epidemiol 147:441-447, 1998
39. Zanchetti A: The hypertensive patient with multiple risk factors: is treatment really so difficult? Am J Hypertens 10:223S-229S, 1997
40. Kannel WB, McGee D, Gordon T: A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 38:46-51, 1976
41. Villablanca AC, McDonald JM, Rutledge JC: Smoking and cardiovascular disease. Clin Chest Med 21:159-172, 2000
42. Hays JT, Hurt RD, Dale LC: Smoking Cessation. In Prevention of Myocardial Infarction. Manson JE, Ridker PM, Gaziano JM, Hennekens CH, Eds. New York, Oxford University Press, 1996, p. 99-129